{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T05:30:24Z","timestamp":1766467824270,"version":"build-2065373602"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p>Juvenile parkinsonism is a disease which is rarely seen in pediatric patients. In addition, drug-induced Parkinson\u2019s syndrome is generally rare in children; however, it represents one of the most severe iatrogenic movement disorders in adults. The authors present one case of genetically confirmed juvenile parkinsonism and two cases of chronic Parkinson\u2019s syndrome induced by psychiatric medication. The aim is to underline the differences between the clinical presentation, laboratory results, and the evolution under treatment. In addition, by reviewing literature data we analyzed the most significant information to describe the differences between these two conditions. Parkinsonian syndromes in pediatric patients and juvenile parkinsonism are difficult to diagnose based solely on clinical presentation because the manifestations are non-specific. Genetic testing and exclusion of other causes is essential for the final diagnosis. Adolescents who are diagnosed with drug-induced parkinsonian syndromes should undergo neurological evaluation, due to the fact that there is a risk of developing idiopathic Parkinson\u2019s disease later during adulthood.<\/jats:p>","DOI":"10.3389\/fgene.2025.1672445","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T22:10:11Z","timestamp":1760047811000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Case Report: Practical approach to differentiating juvenile parkinsonism of genetic cause and drug-induced parkinsonism in adolescents: a case series and literature review"],"prefix":"10.3389","volume":"16","author":[{"given":"Ioana","family":"Grigore","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u0103cr\u0103mioara Ionela","family":"Butnariu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas Gabriel","family":"Schreiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasile Valeriu","family":"Lupu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ancuta","family":"Lupu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludmila","family":"Darie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u0103t\u0103lin","family":"Pr\u0103zaru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"\u021aarc\u0103","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Setalia","family":"Popa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ecaterina","family":"Grigore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1093\/hmg\/8.4.567","article-title":"A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French parkinson's disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease","volume":"8","author":"Abbas","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"400","DOI":"10.3906\/sag-2008-253","article-title":"Dopamine transporter SPECT imaging in Parkinson\u2019s disease and parkinsonian disorders","volume":"51","author":"Akdemir","year":"2021","journal-title":"Turk J. Med. Sci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s13353-015-0282-9","article-title":"Genomic instability in the PARK2 locus is associated with parkinson's disease","volume":"56","author":"Ambroziak","year":"2015","journal-title":"J. Appl. Genet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e5409","DOI":"10.7759\/cureus.5409","article-title":"Juvenile parkinson disease","volume":"1","author":"Anwar","year":"2019","journal-title":"Cureus"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.52793\/ACMR.2024.5(2)-76","article-title":"Drug induced parkinsonism as it compareswith parkinson disease","volume":"5","author":"Benharroch","year":"2024","journal-title":"Adv. Clin. Med. Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1007\/s12311-021-01343-7","article-title":"Resting-state low-frequency cerebellar oscillations can be abnormal in Parkinson\u2019s disease","volume":"21","author":"Bosch","year":"2022","journal-title":"Cerebellum"},{"key":"B7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3389\/fnagi.2017.00003","article-title":"Quantitative EEG (QEEG) measures differentiate Parkinson's disease (PD) patients from healthy Controls (HC)","volume":"9","author":"Chaturvedi","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"48","DOI":"10.5334\/tohm.554","article-title":"Clinical spectrum of drug-induced movement disorders: a Study of 97 patients","volume":"10","author":"Chouksey","year":"2020","journal-title":"Tremor Other Hyperkinet Mov"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1080\/14740338.2024.2418950","article-title":"Drug-induced parkinsonism: diagnosis and treatment","volume":"23","author":"Conn","year":"2024","journal-title":"Expert Opin. Drug Saf."},{"key":"B10","doi-asserted-by":"publisher","first-page":"9060649","DOI":"10.1155\/2016\/9060649","article-title":"Quantitative EEG and cognitive decline in Parkinson\u2019s disease","volume":"2016","author":"Cozac","year":"2016","journal-title":"Park. Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1002\/mds.28112","article-title":"A large-scale full GBA1 gene screening in Parkinson\u2019s disease in the Netherlands","volume":"35","author":"den Heijer","year":"2020","journal-title":"Mov. Disord."},{"key":"B12","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.parkreldis.2017.02.017","article-title":"Olfactory dysfunction and dementia in newly diagnosed patients with Parkinson's disease","volume":"38","author":"Domell\u00f6f","year":"2017","journal-title":"Park. RelatDisord"},{"key":"B13","volume-title":"EEG abnormal waveforms","author":"Emmady","year":"2025"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.2147\/TCRM.S360268","article-title":"Updated perspectives on the management of drug-induced parkinsonism (DIP): insights from the Clinic","volume":"18","author":"Feldman","year":"2022","journal-title":"Ther. Clin. Risk Manag."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2972","DOI":"10.1093\/hmg\/ddw148","article-title":"The endoplasmic reticulum-mitochondria interface is perturbed in PARK2 knockout mice and patients with PARK2 mutations","volume":"25","author":"Gautier","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"B16","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1212\/WNL.0000000000006473","article-title":"Clinical correlates of quantitative EEG in Parkinson disease: a systematic review","volume":"91","author":"Geraedts","year":"2018","journal-title":"Neurology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/ane.13003","article-title":"Hyposmia in a simple smell test is associated with accelerated cognitive decline in early Parkinson's disease","volume":"138","author":"Gjerde","year":"2018","journal-title":"Acta Neurol. Scand."},{"key":"B18","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s11571-013-9247-z","article-title":"Investigation of EEG abnormalities in the early stage of Parkinson's disease","volume":"7","author":"Han","year":"2013","journal-title":"CognNeurodyn"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1007\/s007020100006","article-title":"Clinical characteristics of neuroleptic-induced parkinsonism","volume":"108","author":"Hassin-Baer","year":"2001","journal-title":"J. Neural Transm."},{"key":"B20","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s13312-021-2310-7","article-title":"Movement disorders in children","volume":"58","author":"Jain","year":"2021","journal-title":"Indian Pediatr."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e0247354","DOI":"10.1371\/journal.pone.0247354","article-title":"Drug-induced parkinsonism: a strong predictor of idiopathic Parkinson's disease","volume":"16","author":"Jeong","year":"2021","journal-title":"PLoS One"},{"key":"B22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.17756\/jnen.2017-025","article-title":"Juvenile parkinsonism \u2013 a diagnostic dilemma","volume":"3","author":"Jha","year":"2017","journal-title":"J. Neurol. Exp. Neurosci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3390\/biom14020209","article-title":"EEG frequency correlates with \u03b12-Receptor density in Parkinson's Disease","volume":"14","author":"Kemp","year":"2024","journal-title":"Biomolecules"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.3390\/ph17081099","article-title":"Comprehensive analysis of drug-induced parkinson-like events","volume":"17","author":"Kikegawa","year":"2024","journal-title":"Pharmaceuticals"},{"key":"B25","doi-asserted-by":"publisher","first-page":"64","DOI":"10.14802\/jmd.23105","article-title":"Comparative olfactory profiles in Parkinson's Disease and drug-induced parkinsonism","volume":"17","author":"Kwak","year":"2024","journal-title":"J. Mov. Disord."},{"key":"B26","doi-asserted-by":"publisher","first-page":"3907","DOI":"10.1038\/s41598-023-29547-3","article-title":"Persistent impacts of smoking on resting-state EEG in male chronic smokers and past-smokers with 20 years of abstinence","volume":"13","author":"Lee","year":"2023","journal-title":"Sci. Rep."},{"key":"B27","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1037\/neu0000544","article-title":"Awareness of olfactory dysfunction in Parkinson's disease","volume":"33","author":"Leonhardt","year":"2019","journal-title":"Neuropsychology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"7282","DOI":"10.3390\/ijms21197282","article-title":"A splice intervention therapy for autosomal recessive juvenile Parkinson's Disease arising from parkin mutations","volume":"21","author":"Li","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"6661","DOI":"10.1007\/s00415-022-11278-6","article-title":"A very early onset of juvenile parkinsonism","volume":"269","author":"Magistrelli","year":"2022","journal-title":"J. Neurol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1007\/s00415-018-8913-9","article-title":"Correlation among olfactory function, motors' symptoms, cognitive impairment, apathy, and fatigue in patients with Parkinson's disease","volume":"265","author":"Masala","year":"2018","journal-title":"J. Neurol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1093\/brain\/awz345","article-title":"Clinical and neuroimaging phenotypes of genetic parkinsonism from infancy to adolescence","volume":"143","author":"Morales-Brice\u00f1o","year":"2020","journal-title":"Brain"},{"key":"B32","first-page":"1993","article-title":"Monogenic parkinson disease overview","volume-title":"GeneReviews\u00ae","author":"Morris","year":"2004"},{"key":"B33","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.parkreldis.2019.06.025","article-title":"Juvenile parkinsonism: differential diagnosis, genetics, and treatment","volume":"67","author":"Niemann","year":"2019","journal-title":"Park. RelatDisord"},{"key":"B34","doi-asserted-by":"publisher","first-page":"11234","DOI":"10.3390\/ijms222011234","article-title":"Dopamine transporter imaging, Current status of a potential biomarker: a comprehensive review","volume":"22","author":"Palermo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1212\/WNL.0b013e3181af7a33","article-title":"Parkin dosage mutations have greater pathogenicity in familial PD than simple sequence mutations","volume":"73","author":"Pankratz","year":"2009","journal-title":"Neurology"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e000034","DOI":"10.1136\/bmjno-2019-000034","article-title":"Parkinsonism in the psychiatric setting: an update on clinical differentiation and management","volume":"2","author":"Powell","year":"2020","journal-title":"BMJ Neurol. Open"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JPD-212815","article-title":"A practical approach to early-onset parkinsonism","volume":"12","author":"Riboldi","year":"2022","journal-title":"J. Park. Dis."},{"key":"B38","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1002\/mdc3.13028","article-title":"Association between olfactory impairment and disease severity and duration in Parkinson's Disease","volume":"7","author":"Sasaki","year":"2020","journal-title":"Mov. Disord. Clin. Pract."},{"key":"B39","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.clinph.2024.10.013","article-title":"Low-frequency EEG power and coherence differ between drug-induced parkinsonism and Parkinson's disease","volume":"168","author":"Seo","year":"","journal-title":"Clin. Neurophysiol."},{"key":"B40","article-title":"Quantitative EEG analysis for comparing drug-induced parkinsonism and parkinson\u2019s disease (abstract)","volume":"39","author":"Seo","year":"","journal-title":"Mov. Disord."},{"key":"B41","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3988\/jcn.2012.8.1.15","article-title":"Drug-induced parkinsonism","volume":"8","author":"Shin","year":"2012","journal-title":"J. Clin. Neurol."},{"key":"B42","doi-asserted-by":"crossref","unstructured":"The genome aggregation database\n          \n          \n          2025","DOI":"10.1093\/database\/baaf004"},{"key":"B43","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1007\/s00415-023-11563-y","article-title":"Dopamine transporter single photon emission computed tomography (DaT-SPECT) use in the diagnosis and clinical management of parkinsonism: an 8-year retrospective study","volume":"270","author":"Tsang","year":"2023","journal-title":"J. Neurol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3233\/JPD-191844","article-title":"Neurophysiological biomarkers of parkinson\u2019s disease","volume":"10","author":"Waninger","year":"2020","journal-title":"J. Parkinson\u2019s Dis."},{"key":"B45","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s40120-018-0105-0","article-title":"Antipsychotic-Related movement disorders: Drug-Induced parkinsonism vs. tardive Dyskinesia\u2014Key differences in pathophysiology and clinical management","volume":"7","author":"Ward","year":"2018","journal-title":"Neurol. Ther."},{"key":"B46","doi-asserted-by":"publisher","first-page":"970","DOI":"10.3390\/biomedicines13040970","article-title":"The utilization and impact of dopamine transporter imaging in diagnosing movement disorders at a tertiary care Hospital in Greece","volume":"13","author":"Xiromerisiou","year":"2025","journal-title":"Biomedicines"},{"key":"B47","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.parkreldis.2018.04.037","article-title":"DAT-SPECT imaging in cases of drug-induced parkinsonism in a specialty movement disorders practice","volume":"53","author":"Yomtoob","year":"2018","journal-title":"Park. RelatDisord"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.3390\/jcm12041569","article-title":"The increase of theta power and decrease of alpha\/Theta ratio as a manifestation of cognitive impairment in parkinson\u2019s disease","volume":"12","author":"Zawi\u015blak-Fornagiel","year":"2023","journal-title":"J. Clin. Med."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2025.1672445\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T22:10:13Z","timestamp":1760047813000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2025.1672445\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,10]]},"references-count":48,"alternative-id":["10.3389\/fgene.2025.1672445"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2025.1672445","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,10]]},"article-number":"1672445"}}